In her latest column — Getting to the root of the stem-cell debate — Seattle Times editorial columnist Collin Levey raises a very interesting question: how much does she get paid for this cushy gig?
Does she really make a living writing one 900-word column a week? Taking into account her rigorous methodology, what’s that amount to… half a days work? And more importantly… how do I get this job?
Collin’s idea of exhaustive research is reading the Wall Street Journal in bed, so I viewed with suspicion her call for deeper analysis on the stem-cell debate. “It’s heady stuff, so let’s review a few facts as we wade into the politics,” she writes.
Good idea. But what kind of “facts” does she come up with?
In 2001, the Bush administration limited the federal funding of stem-cell research to some 78 pre-existing stem-cell “lines” from these sources. Of those “lines,” some smaller fraction of them has been useful.
Well, you can’t get much more specific than “some smaller fraction of” can you? Unless you spent 30 seconds searching Google, and found that according to the American Medical Association, the number of useful stem-cell lines was closer to twelve.
Sure… I know I’m quibbling here. But it’s kind of ridiculous for Collin to write that it is “better to err on the side of research and discovery,” and then not do any in preparing her column.